Literature Recap: May 1-15, 2024
Posted in Papers / Original Research / Human Studies / May 1-15, 2024
Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: A randomized clinical trial
Posted on May 14, 2024
Posted in Papers / Original Research / Human Studies / Editor's Picks / May 1-15, 2024
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study
Posted on May 14, 2024
Posted in Papers / Reviews / Editor's Picks / May 1-15, 2024
Prevalence and burden of migraine in the United States: A systematic review
Posted on May 14, 2024
Posted in Papers / Original Research / Human Studies / May 1-15, 2024
Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine
Posted on May 14, 2024
Posted in Papers / Reviews / May 1-15, 2024
Pharmacological management of migraine: current strategies and future directions
Posted on May 14, 2024
Posted in Papers / Commentaries and editorials / May 1-15, 2024
To treat or not to treat? Medication underuse headache, a novel reframing
Posted on May 13, 2024
Posted in Papers / Reviews / May 1-15, 2024
The Dawn and Advancement of the Knowledge of the Genetics of Migraine
Posted on May 11, 2024
Posted in Papers / Reviews / May 1-15, 2024
Switching CGRP(r) MoAbs in migraine: what evidence?
Posted on May 10, 2024
Posted in Papers / Original Research|Reviews / May 1-15, 2024
Ketamine as Treatment for Cluster Headache: A Systematic Review of Literature and a Case Series
Posted on May 9, 2024
Posted in Papers / Original Research / Animal Studies / May 1-15, 2024
Extrasynaptic deltaGABAA receptors mediate resistance to migraine-like phenotype in rats
Posted on May 9, 2024